Legend Biotech Corporation (NASDAQ:LEGN) Q1 2026 Earnings Call Transcript May 12, 2026
Legend Biotech Corporation misses on earnings expectations. Reported EPS is $-0.15 EPS, expectations were $-0.02.
Operator: Good day, and thank you for standing by. Welcome to the Legend Biotech First Quarter 2026 Earnings Conference Call. [Operator Instructions] Today’s conference is being recorded. I will now hand the conference over to your speaker host for today, Jessie Yeung, Vice President of...
